Weight Reduction Medications

Weight Reduction Medications

Some weight loss medications for treating obesity are covered under the New Mexico Medicaid Fee-for-Service program with prior authorization.  

Covered, Prior Authorization RequiredNot Covered by New Mexico Medicaid
Didres (benzphetamine)Imcivree (setmelanotide)
Fastin (phentermine HCL)Saxenda (liraglutide)
Meridia (sibutramine HCL M-hydrate)Wegovy (semaglutide)
Sanorex (mazindol)Zepbound (tirzepatide)
Tenuate (phendimetrazine)
Xenical (orlistat)

 Prior Authorization Criteria

  • BMI >40 or BMI > 35 with additional risk factors (hypertension, diabetes, dyslipidemia), and
  • A six-month trial of caloric restriction and exercise is recommended (not required).

Prior Authorization Process

  • Providers: to obtain prior authorization, when necessary, fax MAD Form 635 to Medical Assistance division at 505-827-3185. Authorization is for an initial three-month period.  Authorization for Meridia and Xenical is continued for a period of one year with significant weight loss (at least 3% body weight loss) and improvement of co-morbid conditions.  Prior approval expires after a three-month period for all drugs indicated for short-term weight loss.

The New Mexico Medicaid program is approved to cover certain medications that are not typically covered by Medicare (see NMAC 8.324.4.12.A). 

For more information contact: MADInfo.HCA@hca.nm.us